5/17/2016

Benzonatate Capsules

Products Affected - Description

- Zonatuss capsule, Vertical, 150 mg, 100 count, NDC 68025-0058-10
- Benzonatate capsule, Caraco, 100 mg, 100 count, NDC 57664-0133-88
- Benzonatate capsule, Caraco, 200 mg, 100 count, NDC 57664-0134-88

Reason for the Shortage

- Amneal and Ascend Laboratories cannot provide a reason for the shortage.
- Caraco discontinued benzonatate capsules in mid-2015.
- Zydus states the reason for the shortage was manufacturing delay.
- Pfizer had Tessalon Perles on shortage due to supply and demand issues.
- Vertical discontinued Zonatuss in 2016.

Available Products

- Tessalon Perles capsule, Pfizer, 100 mg, 100 count, NDC 00069-0122-01
- Benzonatate capsule, Amneal, 100 mg, 100 count, NDC 65162-0536-10
- Benzonatate capsule, Amneal, 100 mg, 500 count, NDC 65162-0536-20
- Benzonatate capsule, Amneal, 200 mg, 100 count, NDC 65162-0537-10
- Benzonatate capsule, Amneal, 200 mg, 500 count, NDC 65162-0537-20
- Benzonatate capsule, Ascend, 100 mg, 100 count, NDC 67877-0105-01
- Benzonatate capsule, Ascend, 100 mg, 500 count, NDC 67877-0105-05
- Benzonatate capsule, Ascend, 200 mg, 100 count, NDC 67877-0106-01
- Benzonatate capsule, Ascend, 200 mg, 500 count, NDC 67877-0106-05
- Benzonatate capsule, Bionpharma, 100 mg, 100 count, NDC 69387-0119-01
- Benzonatate capsule, Bionpharma, 100 mg, 500 count, NDC 69387-0119-05
- Benzonatate capsule, Bionpharma, 200 mg, 100 count, NDC 69387-0120-01
- Benzonatate capsule, Bionpharma, 200 mg, 500 count, NDC 69387-0120-05
- Benzonatate capsule, Major, 100 mg, 100 count, NDC 00904-5904-60
- Benzonatate oral capsule, Tagi Pharma, 200 mg, 100 count, NDC 51224-0001-50
- Benzonatate capsule, Zydus, 100 mg, 100 count, NDC 68382-0247-01

Estimated Resupply Dates

- All marketed presentations are available.

Updated

Updated May 17, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Created January 21, 2015 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.